Literature DB >> 18838384

Tumor necrosis factor-alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor.

Keigan M Park1, David I Yule, William J Bowers.   

Abstract

Inflammatory events have long been implicated in initiating and/or propagating the pathophysiology associated with a number of neurological diseases. In addition, defects in Ca2+-handling processes, which shape membrane potential, influence gene transcription, and affect neuronal spiking patterns, have also been implicated in disease progression and cognitive decline. The mechanisms underlying the purported interplay that exists between neuroinflammation and Ca2+ homeostasis have yet to be defined. Herein, we describe a novel neuron-intrinsic pathway in which the expression of the type-1 inositol 1,4,5-trisphosphate receptor is regulated by the potent pro-inflammatory cytokine tumor necrosis factor-alpha. Exposure of primary murine neurons to tumor necrosis factor-alpha resulted in significant enhancement of Ca2+ signals downstream of muscarinic and purinergic stimulation. An increase in type-1 inositol 1,4,5-trisphosphate receptor mRNA and protein steady-state levels following cytokine exposure positively correlated with this alteration in Ca2+ homeostasis. Modulation of Ca2+ responses arising from this receptor subtype and its downstream effectors may exact significant consequences on neuronal function and could underlie the compromise in neuronal activity observed in the setting of chronic neuroinflammation, such as that associated with Parkinson disease and Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838384      PMCID: PMC2586262          DOI: 10.1074/jbc.M802209200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex.

Authors:  W L Ying; J Emerson; M J Clarke; D R Sanadi
Journal:  Biochemistry       Date:  1991-05-21       Impact factor: 3.162

2.  Identification and characterization of receptors for tumor necrosis factor-alpha in the brain.

Authors:  K Kinouchi; G Brown; G Pasternak; D B Donner
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

3.  A study of mitochondrial and nuclear transcription with cloned cDNA probes. Changes in the relative abundance of mitochondrial transcripts after stimulation of quiescent mouse fibroblasts.

Authors:  D R Edwards; D T Denhardt
Journal:  Exp Cell Res       Date:  1985-03       Impact factor: 3.905

4.  Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles.

Authors:  D E Goeger; R T Riley; J W Dorner; R J Cole
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

5.  Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death.

Authors:  Javier H Jara; Brij B Singh; Angela M Floden; Colin K Combs
Journal:  J Neurochem       Date:  2007-01-11       Impact factor: 5.372

6.  The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.

Authors:  S K Joseph; H L Rice
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

7.  Blockade of current through single calcium channels by trivalent lanthanide cations. Effect of ionic radius on the rates of ion entry and exit.

Authors:  J B Lansman
Journal:  J Gen Physiol       Date:  1990-04       Impact factor: 4.086

8.  Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.

Authors:  A Sica; J M Wang; F Colotta; E Dejana; A Mantovani; J J Oppenheim; C G Larsen; C O Zachariae; K Matsushima
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

9.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

10.  Calcium regulation of neurite elongation and growth cone motility.

Authors:  M P Mattson; S B Kater
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

View more
  22 in total

Review 1.  Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.

Authors:  Yun Yuan; Ming Fang; Chun-Yun Wu; Eng-Ang Ling
Journal:  Neuromolecular Med       Date:  2016-04-21       Impact factor: 3.843

Review 2.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

3.  Androgen Receptor-Mediated Regulation of Intracellular Calcium in Human Airway Smooth Muscle Cells.

Authors:  Rama Satyanarayana Raju Kalidhindi; Rathnavali Katragadda; Kerri L Beauchamp; Christina M Pabelick; Y S Prakash; Venkatachalem Sathish
Journal:  Cell Physiol Biochem       Date:  2019

4.  Tumor necrosis factor-alpha-mediated regulation of the inositol 1,4,5-trisphosphate receptor promoter.

Authors:  Keigan M Park; David I Yule; William J Bowers
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

5.  Impaired TNF-alpha control of IP3R-mediated Ca2+ release in Alzheimer's disease mouse neurons.

Authors:  Keigan M Park; David I Yule; William J Bowers
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

Review 6.  Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction.

Authors:  Keigan M Park; William J Bowers
Journal:  Cell Signal       Date:  2010-01-21       Impact factor: 4.315

Review 7.  Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction.

Authors:  Diana M Sama; Christopher M Norris
Journal:  Ageing Res Rev       Date:  2013-06-08       Impact factor: 10.895

8.  Tumor necrosis factor-alpha-induced reduction of glomerular filtration rate in rats with fulminant hepatic failure.

Authors:  Jing-Bo Wang; Dong-Lei Wang; Hai-Tao Wang; Zhao-Han Wang; Ying Wen; Cui-Ming Sun; Yi-Tong Zhao; Jian Wu; Pei Liu
Journal:  Lab Invest       Date:  2014-06-02       Impact factor: 5.662

9.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

10.  Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.

Authors:  S Prasad Gabbita; Minu K Srivastava; Pirooz Eslami; Ming F Johnson; Naomi K Kobritz; David Tweedie; Nigel H Greig; Frank P Zemlan; Sherven P Sharma; Marni E Harris-White
Journal:  J Neuroinflammation       Date:  2012-05-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.